Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms

Chirajyoti Deb, Allan N. Salinas, Aurea Middleton, Katelyn Kern, Daleen Penoyer, Rahul Borsadia, Charles Hunley, Vijay Mehta, Laura Irastorza, Devendra I. Mehta, Tianyu Zheng, Qun Huo
doi: https://doi.org/10.1101/2020.09.30.20203844
Chirajyoti Deb
1Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health, 110 Bonnie Loch Court, Orlando, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Qun.Huo@ucf.edu chirajyoti.deb@orlandohealth.com devendra.mehta@orlandohealth.com
Allan N. Salinas
1Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health, 110 Bonnie Loch Court, Orlando, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurea Middleton
2Center for Nursing Research, Orlando Health, 1414 Kuhl Ave, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katelyn Kern
3Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health, 60 Gore St., Orlando, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daleen Penoyer
2Center for Nursing Research, Orlando Health, 1414 Kuhl Ave, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahul Borsadia
4Internal Medicine Group, Orlando Health, 1414 Kuhl Ave, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Hunley
5Critical Care Medicine, Orlando Health, 1414 Kuhl Ave, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vijay Mehta
3Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health, 60 Gore St., Orlando, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Irastorza
3Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health, 60 Gore St., Orlando, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devendra I. Mehta
1Translational Research and Specialty Diagnostic Laboratory, Arnold Palmer Hospital for Children, Orlando Health, 110 Bonnie Loch Court, Orlando, FL 32806
3Center for Digestive Health and Nutrition, Arnold Palmer Hospital for Children, Orlando Health, 60 Gore St., Orlando, FL 32806
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Qun.Huo@ucf.edu chirajyoti.deb@orlandohealth.com devendra.mehta@orlandohealth.com
Tianyu Zheng
6Nano Discovery Inc., 1060 Woodcock Road Suite 131, Orlando, FL 32803
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qun Huo
7Department of Chemistry and NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Qun.Huo@ucf.edu chirajyoti.deb@orlandohealth.com devendra.mehta@orlandohealth.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Coronavirus disease 2019 (COVID-19) has brought enormous loss and interruption to human life and the global economy since the first outbreak reported in China between late 2019 to early 2020, and will likely remain a public health threat in the months and years to come. Upon infection with SARS-CoV-2, the virus that causes COVID-19, most people will develop no or mild symptoms, however, a small percentage of the population will become severely ill, require hospitalization, intensive care, and some succumb to death. The current knowledge of COVID-19 disease progression with worsening symptom complex implicates the critical importance of identifying patients with high clinical risk compared to those who would be at lower risk for disease control and patient management with better therapeutic output. Currently no clinical test is available that can predict risk factors and immune status change at different severity scales. The immune system plays a critical role in the defense against infectious diseases. Extensive research has found that COVID-19 patients with poor clinical outcomes differ significantly in their immune responses to the virus from those who exhibit milder symptoms. We previously developed a nanoparticle-enabled blood test that can detect the humoral immune status change in animals. In this study, we applied this new test to analyze the immune response in relation to disease severity in COVID-19 patients. From the testing of 153 COVID-19 patient samples and 142 negative controls, we detected statistically significant differences between COVID-19 patients with no or mild symptoms from those who developed moderate to severe symptoms. Mechanistic study suggests that these differences are associated with type 1 versus type 2 immune responses. We conclude that this new rapid test could potentially become a valuable clinical tool for COVID-19 patient risk stratification and management.

Competing Interest Statement

Dr. Huo reports other from Nano Discovery Inc., outside the submitted work; In addition, Dr. Huo has a patent Detection of Interaction Between an Assay Substance and Blood or Blood Components for Immune Status Evaluation and Immune Related Disease Detection and Diagnosis pending.

Funding Statement

This study is supported by intramural funding from Nano Discovery Inc. and Orlando Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study (OH IRB # 20.095.06) was approved by Orlando Health IRB#2.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted October 02, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms
Chirajyoti Deb, Allan N. Salinas, Aurea Middleton, Katelyn Kern, Daleen Penoyer, Rahul Borsadia, Charles Hunley, Vijay Mehta, Laura Irastorza, Devendra I. Mehta, Tianyu Zheng, Qun Huo
medRxiv 2020.09.30.20203844; doi: https://doi.org/10.1101/2020.09.30.20203844
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms
Chirajyoti Deb, Allan N. Salinas, Aurea Middleton, Katelyn Kern, Daleen Penoyer, Rahul Borsadia, Charles Hunley, Vijay Mehta, Laura Irastorza, Devendra I. Mehta, Tianyu Zheng, Qun Huo
medRxiv 2020.09.30.20203844; doi: https://doi.org/10.1101/2020.09.30.20203844

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8794)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10575)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)